WA
AMGN icon

Wasatch Advisors’s Amgen AMGN Stock Holding History

Wasatch Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-22,540
Closed -$3.92M – 293
2017
Q4 		$3.92M Sell
22,540
-12,508
-36% -$2.21M 0.05% 168
2017
Q3 		$6.54M Hold
35,048
– – 0.09% 142
2017
Q2 		$6.04M Sell
35,048
-7,170
-17% -$1.17M 0.08% 151
2017
Q1 		$6.93M Buy
42,218
+11,623
+38% +$1.93M 0.1% 140
2016
Q4 		$4.47M Buy
+30,595
New +$4.6M 0.07% 179

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wasatch Advisors's AMGN Position: Q1 2018 in Review

Wasatch Advisors sold out of Amgen (AMGN) in Q1 2018, closing a stake of 22,540 shares — an estimated $3.92M sold.

Wasatch Advisors first reported a position in AMGN in Q4 2016 and held it in 5 quarters. The position peaked at $6.93M in Q1 2017. 1,750 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Wasatch Advisors reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
  • Wasatch Advisors sold 22,540 Amgen shares in Q1 2018, an estimated $3.92M.
  • Wasatch Advisors first reported a position in Amgen in Q4 2016 and held it in 5 quarters.
  • Wasatch Advisors's Amgen position peaked at $6.93M in Q1 2017.
  • 1,750 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Wasatch Advisors's 13F filing for Q1 2018, filed 2 May 2018.